Ank Nijhawan is an Infectious Disease physician affiliated with Southwestern Medical Center. OpenAlex indexes 162 publications with 2,952 citations (h-index 27); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5323 Harry Hines Blvd.
Dallas, TX 753907208
Telephone
214-645-2800Registry record last updated 13 Dec 2011.
Clinical trials
- The Unlocking PrEP Study: Integration of Peer Health Navigation Into Comprehensive Re-entry Services
Sponsor: University of Texas Southwestern Medical Center
- RESTORE Study R61 Phase: Recovery and Engagement for Stimulant Users on Re-entry
Sponsor: University of Texas Southwestern Medical Center
- HOTSPOT Study: Implement and Evaluate the PrEP (Pre-exposure Prophylaxis) Implementation Strategy
Sponsor: University of Texas Southwestern Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Gilead Sciences, Inc.Program year20242 payments
- Gilead Sciences, Inc.Program year20231 payment
- Gilead Sciences, Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
32.9%Protease Inhibitor11.6%Prezcobix52%Atazanavir Sulfate25%Symtuza23%Part D<11 patientsHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor9.6%Triumeq61%Descovy40%Part D<11 patients+ 2 more classes in this area
Cardiovascular
26.9%Statin10%Atorvastatin Calcium56%Pravastatin Sodium44%Part D<11 patientsACE inhibitor6.7%Lisinopril100%Part D<11 patients+ 3 more classes in this area
Respiratory
12.9%beta2-Adrenergic Agonist9.8%Albuterol Sulfate Hfa100%Part D<11 patientsOpioid Agonist3.1%Hydrocodone-Acetaminophen100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
4 NIH research awards on record, funded 2015–2026 per NIH RePORTER. The latest:
- Hybrid implementation-effectiveness study to optimize HIV testing and PrEP in a southern jail (HOTSPOT)
Ut Southwestern Medical Center
FY2026$659,566R01MH129185 - RESTORE (Recovery and Engagement for STimulant users On Re-entry)
Ut Southwestern Medical Center
FY2026$624,775R61DA064030 - RESTORE (Recovery and Engagement for STimulant users On Re-entry)
Ut Southwestern Medical Center
FY2025$660,104R61DA064030
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- High Seroprevalence of Kaposi Sarcoma–Associated Herpesvirus in Men Who Have Sex With Men With HIV in the Southern United States
Open Forum Infectious Diseases
2023 - Severe Monkeypox in Hospitalized Patients — United States, August 10–October 10, 2022
MMWR Morbidity and Mortality Weekly Report
2022 - Prevalence and Management of Sexually Transmitted Infections in Correctional Settings: A Systematic Review
Clinical Infectious Diseases
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Claus Roehrborn, MD
Southwestern Medical Center
Trish Perl, MD
Southwestern Medical Center
Lisa Vanwagner, MD
Southwestern Medical Center
Jose Joglar, MD
Southwestern Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”